Asia IP Exchange is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Search Results 
Sort by Title | Sort by Popularity
Vim3 and Mxi-2 Antibody
3485:Liquid biopsy: non-invasive test for preoperative diagnosis and differentiation of benign and malignant renal carcinoma. [Detail]
Tags: Liquid biopsy, urine, urine diagnostics, tumor tissue, diagnostic medical dipstic, ELISA, preoperative marker, differential diagnosis, non-invasive, differentiation of benign and malignant tumors, renal tumor, kidney tumor, renal cell carcinoma, oncocytoma, antibody, Vimentin, Vimentin 3, MAPK p38, Mxi-2
Vim3 and Mxi-2 Antibody
3485:Liquid biopsy: non-invasive test for preoperative diagnosis and differentiation of benign and malignant renal carcinoma. [Detail]
Tags: Liquid biopsy, urine, urine diagnostics, tumor tissue, diagnostic medical dipstic, ELISA, preoperative marker, differential diagnosis, non-invasive, differentiation of benign and malignant tumors, renal tumor, kidney tumor, renal cell carcinoma, oncocytoma, antibody, Vimentin, Vimentin 3, MAPK p38, Mxi-2
Vim3 and Mxi-2 Antibody
3485:Liquid biopsy: non-invasive test for preoperative diagnosis and differentiation of benign and malignant renal carcinoma. [Detail]
Tags: Liquid biopsy, urine, urine diagnostics, tumor tissue, diagnostic medical dipstic, ELISA, preoperative marker, differential diagnosis, non-invasive, differentiation of benign and malignant tumors, renal tumor, kidney tumor, renal cell carcinoma, oncocytoma, antibody, Vimentin, Vimentin 3, MAPK p38, Mxi-2
Vim3 and Mxi-2 Antibody
3485:Liquid biopsy: non-invasive test for preoperative diagnosis and differentiation of benign and malignant renal carcinoma. [Detail]
Tags: Liquid biopsy, urine, urine diagnostics, tumor tissue, diagnostic medical dipstic, ELISA, preoperative marker, differential diagnosis, non-invasive, differentiation of benign and malignant tumors, renal tumor, kidney tumor, renal cell carcinoma, oncocytoma, antibody, Vimentin, Vimentin 3, MAPK p38, Mxi-2
Vim3 and Mxi-2 Antibody
3485:Liquid biopsy: non-invasive test for preoperative diagnosis and differentiation of benign and malignant renal carcinoma. [Detail]
Tags: Liquid biopsy, urine, urine diagnostics, tumor tissue, diagnostic medical dipstic, ELISA, preoperative marker, differential diagnosis, non-invasive, differentiation of benign and malignant tumors, renal tumor, kidney tumor, renal cell carcinoma, oncocytoma, antibody, Vimentin, Vimentin 3, MAPK p38, Mxi-2
  [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] ->  >|
Tag Cloud
wireless Cancer Technology Transfer Office: Patents electrical engineering Devices chemicals Antibody Engineering Nanotechnology Oncology medical Research Tools materials Biotechnology Other none Electronics Engineering/ Computer Science therapeutic Diagnostics Therapeutics Software Disease: Cancer screening physical science Life Science Research Tool Health imaging Polymers
Mobile Device